Report Detail
Global Human DNA Vaccines Market Size, Status and Forecast 2019-2025
- RnM3658946 |
- 09 August, 2019 |
- Global |
- 98 Pages |
- QYResearch |
- Other
DNA vaccines have evolved greatly over the last 20 years since their invention, but have yet to become a competitive alternative to conventional protein or carbohydrate based human vaccines. Whilst safety concerns were an initial barrier, the Achilles heel of DNA vaccines remains their poor immunogenicity when compared to protein vaccines. A wide variety of strategies have been developed to optimize DNA vaccine immunogenicity, including codon optimization, genetic adjuvants, electroporation and sophisticated prime-boost regimens, with each of these methods having its advantages and limitations. Whilst each of these methods has contributed to incremental improvements in DNA vaccine efficacy, more is still needed if human DNA vaccines are to succeed commercially.
In 2018, the global Human DNA Vaccines market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Human DNA Vaccines status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Human DNA Vaccines development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer-Ingelheim
Indian Immunologicals
Plumbline Life Sciences
Market segment by Type, the product can be split into
Recombinant Protein Vaccine
Gene-Based Vaccine
Market segment by Application, split into
Influenza
Human Papillomavirus
HIV
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Human DNA Vaccines status, future forecast, growth opportunity, key market and key players.
To present the Human DNA Vaccines development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Human DNA Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Human DNA Vaccines Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Recombinant Protein Vaccine
- 1.4.3 Gene-Based Vaccine
- 1.5 Market by Application
- 1.5.1 Global Human DNA Vaccines Market Share by Application (2019-2025)
- 1.5.2 Influenza
- 1.5.3 Human Papillomavirus
- 1.5.4 HIV
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Human DNA Vaccines Market Size
- 2.2 Human DNA Vaccines Growth Trends by Regions
- 2.2.1 Human DNA Vaccines Market Size by Regions (2019-2025)
- 2.2.2 Human DNA Vaccines Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
- 3.1 Human DNA Vaccines Market Size by by Players
- 3.1.1 Global Human DNA Vaccines Revenue by by Players (2014-2019)
- 3.1.2 Global Human DNA Vaccines Revenue Market Share by by Players (2014-2019)
- 3.1.3 Global Human DNA Vaccines Market Concentration Ratio (CR5 and HHI)
- 3.2 Human DNA Vaccines Key Players Head office and Area Served
- 3.3 Key Players Human DNA Vaccines Product/Solution/Service
- 3.4 Date of Enter into Human DNA Vaccines Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Human DNA Vaccines Market Size by Type (2014-2019)
- 4.2 Global Human DNA Vaccines Market Size by Application (2014-2019)
5 North America
- 5.1 North America Human DNA Vaccines Market Size (2014-2019)
- 5.2 Human DNA Vaccines Key Players in North America
- 5.3 North America Human DNA Vaccines Market Size by Type
- 5.4 North America Human DNA Vaccines Market Size by Application
6 Europe
- 6.1 Europe Human DNA Vaccines Market Size (2014-2019)
- 6.2 Human DNA Vaccines Key Players in Europe
- 6.3 Europe Human DNA Vaccines Market Size by Type
- 6.4 Europe Human DNA Vaccines Market Size by Application
7 China
- 7.1 China Human DNA Vaccines Market Size (2014-2019)
- 7.2 Human DNA Vaccines Key Players in China
- 7.3 China Human DNA Vaccines Market Size by Type
- 7.4 China Human DNA Vaccines Market Size by Application
8 Japan
- 8.1 Japan Human DNA Vaccines Market Size (2014-2019)
- 8.2 Human DNA Vaccines Key Players in Japan
- 8.3 Japan Human DNA Vaccines Market Size by Type
- 8.4 Japan Human DNA Vaccines Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Human DNA Vaccines Market Size (2014-2019)
- 9.2 Human DNA Vaccines Key Players in Southeast Asia
- 9.3 Southeast Asia Human DNA Vaccines Market Size by Type
- 9.4 Southeast Asia Human DNA Vaccines Market Size by Application
10 India
- 10.1 India Human DNA Vaccines Market Size (2014-2019)
- 10.2 Human DNA Vaccines Key Players in India
- 10.3 India Human DNA Vaccines Market Size by Type
- 10.4 India Human DNA Vaccines Market Size by Application
11 Central & South America
- 11.1 Central & South America Human DNA Vaccines Market Size (2014-2019)
- 11.2 Human DNA Vaccines Key Players in Central & South America
- 11.3 Central & South America Human DNA Vaccines Market Size by Type
- 11.4 Central & South America Human DNA Vaccines Market Size by Application
12 International Players Profiles
- 12.1 Merck
- 12.1.1 Merck Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Human DNA Vaccines Introduction
- 12.1.4 Merck Revenue in Human DNA Vaccines Business (2014-2019))
- 12.1.5 Merck Recent Development
- 12.2 GSK
- 12.2.1 GSK Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Human DNA Vaccines Introduction
- 12.2.4 GSK Revenue in Human DNA Vaccines Business (2014-2019)
- 12.2.5 GSK Recent Development
- 12.3 Sanofi
- 12.3.1 Sanofi Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Human DNA Vaccines Introduction
- 12.3.4 Sanofi Revenue in Human DNA Vaccines Business (2014-2019)
- 12.3.5 Sanofi Recent Development
- 12.4 Zoties
- 12.4.1 Zoties Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Human DNA Vaccines Introduction
- 12.4.4 Zoties Revenue in Human DNA Vaccines Business (2014-2019)
- 12.4.5 Zoties Recent Development
- 12.5 Elanco
- 12.5.1 Elanco Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Human DNA Vaccines Introduction
- 12.5.4 Elanco Revenue in Human DNA Vaccines Business (2014-2019)
- 12.5.5 Elanco Recent Development
- 12.6 Boehringer-Ingelheim
- 12.6.1 Boehringer-Ingelheim Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Human DNA Vaccines Introduction
- 12.6.4 Boehringer-Ingelheim Revenue in Human DNA Vaccines Business (2014-2019)
- 12.6.5 Boehringer-Ingelheim Recent Development
- 12.7 Indian Immunologicals
- 12.7.1 Indian Immunologicals Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Human DNA Vaccines Introduction
- 12.7.4 Indian Immunologicals Revenue in Human DNA Vaccines Business (2014-2019)
- 12.7.5 Indian Immunologicals Recent Development
- 12.8 Plumbline Life Sciences
- 12.8.1 Plumbline Life Sciences Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Human DNA Vaccines Introduction
- 12.8.4 Plumbline Life Sciences Revenue in Human DNA Vaccines Business (2014-2019)
- 12.8.5 Plumbline Life Sciences Recent Development
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Product (2019-2025)
- 13.2 Market Size Forecast by Application (2019-2025)
- 13.3 Market Size Forecast by Regions
- 13.4 North America
- 13.5 Europe
- 13.6 China
- 13.7 Japan
- 13.8 Southeast Asia
- 13.9 India
- 13.10 Central & South America
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 15.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Human DNA Vaccines . Industry analysis & Market Report on Human DNA Vaccines is a syndicated market report, published as Global Human DNA Vaccines Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Human DNA Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
